Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 5,825
Sponsored by: The Breast Cancer Site

Today, the vast majority of medical research is done on men, with women compromising only one-third of test subjects.

The cause and rationale behind this is a long and complex one. In 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. Women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

But for those women who are willing to participate in medical research studies, all of the above facts are reasons why men and women must be separated when it comes to medical research.

Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

Clearly, something needs to be done. Women's health needs cannot be ignored any longer. While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Ask the FDA Center for Drug Evaluation and Research to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Sign Here






To the Director of the FDA Center for Drug Evaluation and Research,

I am writing to you today to express my concern after discovering that the FDA does not require medical research and drug trials to separate their findings by the sex of their participants. To get better data on the way women respond to specific drugs and treatment, this must change.

As you are no doubt aware, women and men do not always display the same signs, symptoms, or reactions to treatment. Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

I understand that in 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. I also realize that women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Women need to benefit from medical trials by having researchers separate their data by sex. Please, change your policies to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Thank you,

Petition Signatures


Feb 17, 2018 LESLIE NEELY
Feb 14, 2018 (Name not displayed)
Feb 14, 2018 Jan Tunnicliff All woman need to be included as part of the clinical trials for breast cancer. Also the sex of partipants need to be separate..
Feb 14, 2018 Beverly Brzycki
Feb 14, 2018 (Name not displayed)
Feb 14, 2018 Darren Spies
Feb 14, 2018 Maria Rivera-Duncan
Feb 14, 2018 donna Selquist
Feb 14, 2018 Lisa Shantz
Feb 14, 2018 Chizuko Walter
Feb 14, 2018 (Name not displayed)
Feb 13, 2018 Bonnie Steiger
Feb 13, 2018 Maggie Alk
Feb 12, 2018 Jill Martin
Feb 12, 2018 Susan Hinckley-Porter
Feb 12, 2018 John Moszyk
Feb 10, 2018 Paul Grohman
Feb 8, 2018 Anne-Marie Henkes
Feb 8, 2018 Gisèle De Mulder
Feb 7, 2018 Flora Psarianos
Feb 6, 2018 Vicki Bingo
Feb 6, 2018 Renato Volo
Feb 6, 2018 Sara Bakker
Feb 6, 2018 Inessa Shakhnazarian
Feb 6, 2018 Ashley Conover
Feb 6, 2018 Eva Avrampou
Feb 5, 2018 (Name not displayed)
Feb 5, 2018 Judith Hazelton
Feb 5, 2018 Lynn Brown
Feb 5, 2018 Maria Day
Feb 5, 2018 María Florencia Martínez
Feb 5, 2018 Samantha VanDusen
Feb 5, 2018 Heinz-Helmut Umbreit
Feb 5, 2018 (Name not displayed)
Feb 5, 2018 (Name not displayed)
Feb 5, 2018 Saliha BELKHIR
Feb 5, 2018 Georgeanne Matranga
Feb 5, 2018 Kim Holec
Feb 5, 2018 PRITHA GHOSH
Feb 4, 2018 Cristina Jercan
Feb 4, 2018 Sieglinda Preez
Feb 4, 2018 Amy Hile
Feb 4, 2018 (Name not displayed)
Feb 4, 2018 Cathy Thornburn
Feb 4, 2018 Beth Patterson
Feb 4, 2018 Margaret Schultz
Feb 4, 2018 Judith Busse
Feb 4, 2018 Fuji Takashi
Feb 4, 2018 Cassandra Williams
Feb 4, 2018 Bethany Fay Studies must distinguish between male and female subjects!

back to top

Bag-tastic Savings
Mason Jar Solar Light
Share this page and help fund mammograms: